All about Acomplia (Rimonabant)
Wed, 19 Nov 2008


Search:
  • Home
  • About
    • spacer
    11
    Jun

    Obesity Market Growing

    Posted by: yorik2002
    in Acomplia, Weight Loss

    According to the data provided by the Decision Resources Research company, the market of anti-obesity medications and therapies is likely to grow five times by the year 2016.
    The company’s analysts anticipate that the market worth approximately $478 million 2 years ago will reach almost $3 billion within the next 8 years in the USA and Western Europe.

    The report projects that such an incredible market growth will be mostly driven by the expected launch of a number of therapies such as Lorcaserin manufactured by Arena Pharmaceuticals and a combination of Pramlintide and Leptin delivered by Amylin. However, the report also predicts that the cautious attitude of the FDA towards the newly developed anti-obesity medications can significantly slow down the projected growth rates. The authors of the report base their opinion on the case of Rimonabant (Acomplia) manufactured by Sanofi-Aventis and the safety concerns over similar drugs in the class such as tranabant.

    no comment
    spacer

    Wordpress by DrugsPill.com